PUNE, India, Sept. 24, 2026 /PRNewswire/ -- Global Placenta Market was valued at USD 96.1 Billion in 2025 and is projected to expand at a 12.4% CAGR from 2026 to 2034, reaching USD 275.18 Billion by 2034, according to a new analysis by Maximize Market Research.

Global Placenta Market

The Global Placenta Market Report 2025 provides a comprehensive analysis of market trends, placenta-derived product demand, product development, application areas, industry dynamics, competitive landscape, regional opportunities, and market forecasts through 2034. The market covers placenta extracts and placenta-based products across powder, liquid, and gel forms, with applications spanning pharmaceuticals, cosmetics, dietary supplements, and other emerging uses. The market also evaluates placenta sources including porcine, equine, ovine, and other types, with hospitals, clinics, research laboratories, and other end users contributing to market demand.

The growing use of placenta-derived ingredients in cosmetic formulations, pharmaceutical products, and dietary supplements, increasing consumer interest in specialized skincare and wellness products, and expanding research into the functional properties of placenta extracts are supporting the development of the global placenta market. Cosmetics represent a high-potential application, supported by the increasing incorporation of placenta-derived ingredients into creams, serums, skincare formulations, and other beauty products. The established use of porcine placenta in placenta-based products further contributes to demand across key applications.

Advancements in placenta extraction, formulation technologies, bioactive ingredient development, skincare applications, pharmaceutical research, and supplement formulations are creating new opportunities across the placenta product landscape. Increasing product development, application-specific formulations, research activities, and expansion of placenta-derived products across North America, Europe, Asia Pacific, Middle East & Africa, and South America are expected to influence market development through 2034.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.maximizemarketresearch.com/request-sample/208753/

Global Placenta Market gains momentum as rising demand for placenta-derived cosmetics, pharmaceuticals and dietary supplements, expanding applications of placenta extracts and placenta-based products, increasing adoption of specialized skincare formulations, and continued product development across key end-use industries accelerate market opportunities: Maximize Market Research unveils key market insights.

Global Placenta Market Size & Forecast

Global Placenta Market Trends & Insights

- Asia-Pacific leads the Global Placenta Market, supported by strong placenta research and development activities in Japan, South Korea, and China, expanding pharmaceutical and cosmetics applications, increasing production of placenta-derived products, and strong consumer interest in skincare and anti-aging products.

- North America and Europe present significant market opportunities, driven by increasing interest in placenta extracts, placenta-based products, pharmaceutical applications, cosmetic formulations, dietary supplements, and ongoing research into placenta-derived ingredients.

- Placenta-based cosmetics are gaining strong demand, with increasing use of placenta extracts in creams, serums, skincare formulations, hair care products, and anti-aging solutions. The cosmetics segment represents a high-potential application area within the placenta market.

- Porcine placenta remains an important source type, supported by its established use in placenta-derived products, while equine, ovine, and other placenta sources contribute to product diversification across pharmaceutical, cosmetics, and dietary supplement applications.

- Product development and formulation innovation are shaping the market, with placenta extracts and placenta-based products being developed in powder, liquid, and gel forms for applications across pharmaceuticals, cosmetics, dietary supplements, and other emerging uses.

Increasing Demand for Placenta-Based Cosmetics Drives Market Growth

The growing demand for placenta-based cosmetics, skincare, hair care, and anti-aging products is supporting the expansion of the Global Placenta Market. Increasing consumer interest in specialized skincare formulations, including placenta extracts, creams, serums, and other placenta-derived cosmetic products, is creating stronger demand across the cosmetics segment. The growing focus on skin health, anti-aging solutions, and premium beauty products is further increasing the use of placenta-derived ingredients.

Ethical Concerns and Regulatory Complexities Restrain Market Growth

Ethical concerns surrounding placenta sourcing and utilization, along with regulatory requirements for placenta-derived products, can restrict market expansion. Differences in regulations governing animal-derived ingredients, placenta extracts, pharmaceutical applications, cosmetics, dietary supplements, product safety, quality standards, and manufacturing processes can increase compliance requirements for manufacturers and limit commercialization across certain markets.

Increasing Pharmaceutical and Research Applications Create Opportunities

Growing research and development activities surrounding placenta-derived materials are creating opportunities across pharmaceutical and other specialized applications. Continued investigation into the functional properties of placenta extracts and placenta-based products, combined with investment in biotechnology, pharmaceutical research, and product development, can support new applications. Opportunities are also emerging through the development of powder, liquid, and gel formulations for pharmaceutical, cosmetics, and dietary supplement applications.

Limited Standardization and Product Quality Create Challenges

Variations in placenta sourcing, extraction methods, processing technologies, formulation quality, regulatory standards, and product consistency can create challenges for market participants. Differences in the availability and quality of porcine, equine, ovine, and other placenta sources may affect manufacturing and product development. Limited standardization across placenta-derived products can also influence consumer acceptance, pharmaceutical applications, cosmetics formulations, dietary supplements, and market expansion in developing regions.

Get Insightful Data on Regions, Market Segments, Customer Landscape, and Top Companies (Charts, Tables, Figures and More) https://www.maximizemarketresearch.com/request-sample/208753/

Global Placenta Market Segmentation

The Global Placenta Market is segmented by Product Type, Form, Type, Application, End-User, and Region. Increasing demand for placenta extracts and placenta-based products, expanding use in cosmetics, pharmaceuticals, and dietary supplements, growing interest in anti-aging skincare and hair care products, and continued placenta research and development are supporting market opportunities across these segments.

Asia Pacific Dominates the Global Placenta Market as Regional Demand and Innovation Accelerate

Asia Pacific held the leading position in the Global Placenta Market in 2025, supported by strong placenta research and development, increasing production of placenta-derived products, and expanding applications across the pharmaceutical and cosmetics industries. Japan, South Korea, and China are important markets due to their established activity in placenta research, pharmaceutical applications, cosmetic formulations, skincare, and anti-aging products. The region's large consumer base and strong demand for skincare, anti-aging solutions, placenta extracts, and placenta-based products further support regional market development.

North America represents an important market for placenta extracts, placenta-based products, pharmaceutical applications, cosmetics, dietary supplements, and research activities. The United States and Canada provide opportunities for product development, biotechnology research, and commercialization of placenta-derived products. Increasing interest in specialized skincare formulations, advanced cosmetic ingredients, and research-based applications is contributing to regional demand.

Europe is an established market supported by increasing interest in placenta-derived ingredients, pharmaceutical research, cosmetics, dietary supplements, and specialized skincare products. Countries including the United Kingdom, France, Germany, Italy, Spain, Sweden, and Austria contribute to regional market development. Product quality, regulatory compliance, research activity, and growing demand for premium skincare and anti-aging formulations influence the European placenta market.

Middle East & Africa represents an emerging market with opportunities across cosmetics, skincare, dietary supplements, pharmaceutical applications, and placenta-based products. The GCC countries, South Africa, Egypt, Nigeria, and other regional markets are contributing to demand as consumer interest in premium beauty, wellness, and specialized cosmetic formulations expands. Improving distribution networks and increasing availability of placenta-derived products can further support regional development.

South America is developing through growing interest in cosmetics, skincare, dietary supplements, and placenta extracts. Brazil, Argentina, and other South American countries offer opportunities for manufacturers and suppliers of placenta-based products, particularly as consumer demand for beauty, wellness, anti-aging, and specialized skincare formulations increases.

Leading Companies Strengthen the Placenta Market Landscape

Agri-Lab Co-Products, TelaGen, Japan Natural Laboratories Co., Ltd., MiMedx Group, Inc.

ONTARIO, Calif., Sep 24, 2026 /PRNewswire/ -- Led by a 31% surge in international travel, Ontario International Airport (ONT) passenger volumes climbed to almost 4.7 million over the first eight months of the year—up 0.3% from the year before.

ONT served more than 450,000 international fliers during the first eight months, reflecting an increased number of flights to Taiwan and Mexico.

For the month of August, the Southern California gateway welcomed 606,000 air travelers, down 6.2% from August 2025 as airlines reduced capacity due to higher fuel prices.

"Ontario International continues to strengthen its position as Southern California's airport of choice, and the tremendous growth we're seeing in international travel is especially exciting," said Atif Elkadi, chief executive officer of the Ontario International Airport Authority (OIAA). "Travelers are choosing ONT for the convenience and ease we offer, the quality of our facilities and amenities, and a customer experience that ranks among the very best in North America. That combination continues to distinguish Ontario in an increasingly competitive aviation market."

The air carriers with the greatest passenger shares in August were:

- Southwest Airlines (35.3%)

- American Airlines (12.9%)

- Alaska Airlines (11.1%)

- Frontier Airlines (11.0%)

- Delta Air Lines (9.7%)

The recently released JD Power 2026 North America Airport Satisfaction Study ranked ONT highest of any California airport of any size with a score of 705 on a 1,000-point scale, the only airport in the Golden State to score above 700. Ontario International also ranked second among medium-size airports across North America.

Meanwhile, cargo volumes through ONT climbed 3.3% in August compared to a year ago, and are up 6.5% year-to-date.

"Ontario International has long been one of the nation's most important air cargo hubs, and these numbers reinforce the critical role we play in the regional and national supply chain," Elkadi said. "Our world-class facilities, strategic location and outstanding airport partners have made ONT a preferred gateway for moving goods quickly and efficiently, and the continued growth in freight volumes speaks to the strength of that partnership."

About Ontario International Airport

Ontario International Airport (ONT) serves more than 7 million passengers per year and offers nonstop service to two dozen major airports in the U.S., Mexico, Central America and Taiwan. ONT is owned and operated by the Ontario International Airport Authority, a Joint Powers Agreement between the City of Ontario and the San Bernardino County. More information is available at flyOntario.com. Follow @flyONT on Facebook, X and Instagram

OIAA Media Contact:

Steve Lambert (909) 841-7527 [email protected]

SOURCE Ontario International Airport

Share this article

Kinross Gold shares gapped down more than 10% in midday trading on September 24, 2026 after the Company cut its 2026-2027 production outlook. SueWallSt notifies investors of a pending investigation into potential securities law violations.

NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Kinross Gold Corporation (NYSE: KGC) fell sharply when the market opened on September 24, 2026, and by midday had fallen to a more than 10% decline. If you lost money on Kinross Gold, you are encouraged to click here to submit your KGC losses. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (888) SueWallSt.

The repricing followed the Company's September 23, 2026 operational update. Kinross stated that 2026-2027 attributable production would be approximately 1.84 to 1.86 million gold equivalent ounces annually -- 2% to 3% below the low end of prior guidance, and, as reported by Mining.com, roughly 8% below the previous guidance midpoint. Reported 2026 all-in sustaining cost guidance was approximately $1,850 to $1,900 per ounce.

The Company partially blamed "lower mining rates and lower than expected grades and recoveries" at Round Mountain Phase S. Management had previously indicated that "[h]igher grade, higher recovery ore is expected from Phase S in the second half of the year."

Shareholders who lost money on Kinross Gold may have their KGC losses reviewed at no cost, or contact Joseph E. Levi, Esq. at [email protected] or (888) SueWallSt.

WHY SUEWALLST: SueWallSt is powered by Levi & Korsinsky LLP. Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

Frequently Asked Questions About the KGC Investigation

Q: How much did KGC stock drop?A: Shares traded down more than 10% by midday on September 24, 2026, after the Company disclosed that 2026-2027 gold production would come in below prior guidance. Investors who purchased shares and suffered losses may be eligible to seek recovery.

Q: Which statements are being investigated as potentially misleading?A: The investigation concerns whether Kinross Gold made materially false or misleading statements regarding its 2026-2027 production outlook and operating conditions at La Coipa and Round Mountain. When the Company disclosed the reduced production guidance and higher expected costs, the stock price declined sharply.

Q: When did Kinross Gold allegedly mislead investors?A: The investigation concerns statements made before the September 23, 2026 operational update that allegedly caused investors to purchase securities at inflated prices.

Q: What do KGC investors need to do right now?A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery. No immediate action is required to remain eligible to participate in the investigation.

Q: What documents do I need to participate?A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What if I already sold my KGC shares -- can I still recover losses?A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought KGC and sold at a loss may still participate in the investigation.

Q: What does it cost me to participate?A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys' fees and expenses subject to court approval.

Q: What if I live outside the United States?A: U.S. securities fraud investigations generally cover purchases on U.S. exchanges regardless of the investor's country of residence.

CONTACT:\

Levi & Korsinsky, LLP\

Joseph E. Levi, Esq.\

33 Whitehall Street, 27th Floor\

New York, NY 10004\

[email protected]\

Tel: (888) SueWallSt\

Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.

SOURCE SueWallSt.com

Share this article

Forge commits $30 million to webAI as the companies partner to build and deploy private, specialized AI systems inside enterprises.

AUSTIN, Texas, Sept. 24, 2026 /PRNewswire/ -- webAI today announced a strategic partnership with Forge AI Deployment, which is making a $30 million commitment to webAI to build and deploy private, specialized AI systems for enterprise customers.

The partnership pairs webAI's collaborative intelligence platform with Forge's enterprise deployment and services operation. Forge will work directly with customers to build AI systems around their proprietary data, workflows and operations, running on infrastructure those customers control.

The agreement comes as the AI market begins shifting from building increasingly capable general-purpose models to putting specialized intelligence to work inside businesses.

Forge is led by enterprise technology veterans, including founder and CEO John Ezzell, who previously built an Oracle-focused services and reseller business that was acquired by Deloitte. Forge is applying a similar playbook to AI: combining a new technology platform with the implementation, integration and operational expertise required to make it useful inside large organizations.

webAI provides the intelligence layer behind that effort.

Rather than relying solely on a general-purpose model, webAI enables organizations to deploy specialized models around their own data, people and operations. Those models can run across infrastructure the organization controls and collaborate as a system.

Forge will design, deploy and operate those systems for customers, from individual specialized AI Personas to company-wide deployments.

"A general model is only the beginning," said David Stout, co-founder and CEO of webAI. "Individuals and organizations need intelligence deeply specialized to them. We believe the path to super intelligence (SI) isn't one model that knows everything; it's specialized intelligence working together. Collaboration gets us there faster."

From AI models to AI infrastructure

webAI calls this emerging architecture the decision factory: intelligence built around the unique knowledge, expertise and workflows of an organization and deployed wherever decisions are made.

Instead of relying on a single general-purpose model, specialized AI Personas can operate as domain experts and work together across webAI's Intelligence Delivery Network (IDN), a private network of compute controlled by the organization.

Forge will take responsibility for turning that technology into working enterprise systems, including architecture, secure deployment, model integration and optimization.

"Enterprises don't need another AI demo," said John Ezzell, founder and CEO of Forge AI Deployment. "They need AI that actually works inside their business. The opportunity is to take this technology from experimentation to production, and webAI gives us the infrastructure to do that."

The partnership also expands webAI's growing ecosystem of systems integrators, software companies and channel partners building, deploying and distributing specialized AI solutions on its platform across commercial and public-sector markets.

For enterprises, the shift is simple: AI stops being something they subscribe to and becomes intelligence they own.

About webAI

webAI is building collaborative intelligence: a private, local-first approach to AI in which specialized models run close to where work happens and collaborate with one another and the people they support. webAI enables individuals and organizations to create, own and deploy specialized intelligence across their own devices and environments. Headquartered in Austin, Texas, webAI's mission is to make powerful AI accessible, personal and collaborative. Learn more at webai.com.

About Forge AI Deployment

Forge AI Deployment is an official webAI systems integrator that designs, installs and operates sovereign AI systems inside infrastructure customers control, including enterprise data centers, edge sites and air-gapped or disconnected enclaves. Combining more than two decades of work in high-consequence and Fortune 100 environments with webAI's local-first platform, Forge provides end-to-end architecture, secure deployment, model integration and optimization while keeping institutional knowledge within the customer's perimeter.

Media Contact

[email protected]

SOURCE webAI

Share this article

WASHINGTON, Sept. 24, 2026 /PRNewswire/ -- In response to a letter from U.S. Senator Elizabeth Warren (D-Mass.), state insurance regulators leading the National Association of Insurance Commissioners (NAIC) today detailed how the state-based regulatory framework is evolving alongside insurers' changing investment strategies, ownership structures, and risk-transfer arrangements.

"Rather than relying on a static regulatory framework, regulators have regularly updated capital requirements, reporting standards, supervisory tools, and analytical capabilities to address emerging risks while maintaining a consistent focus on insurer solvency and policyholder protection," said NAIC leadership.

Among other actions, this work includes:

- Strengthening asset-adequacy testing through Actuarial Guideline 53 (AG 53) to provide greater consistency in evaluating the risks associated with complex and higher-yielding assets supporting life insurance business.

- Intensifying oversight of certain life insurance and annuity reinsurance transactions through Actuarial Guideline 55 (AG 55), including setting higher expectations for asset-adequacy analysis and reserve adequacy.

- Instituting a 45% risk-based capital charge for residual interests in structured securities to ensure that capital requirements appropriately recognize investment risk.

- Creating a formal process for evaluating whether credit rating providers' methodologies and rating mappings remain appropriate for regulatory purposes.

As NAIC leaders noted, "State insurance regulators continually evaluate whether the solvency framework appropriately captures emerging and changing risks."

This adaptive approach, built on collaboration and coordination, has enabled state-based insurance regulation to lead for more than 150 years and will continue to guide it in an ever-changing insurance landscape.

Resources

NAIC Resource Center: Private Credit and Insurance Regulation

State-Based Regulatory Timeline for NAIC's Solvency Oversight

About the National Association of Insurance Commissioners

As part of our state-based system of insurance regulation in the United States, the National Association of Insurance Commissioners (NAIC) provides expertise, data, and analysis for insurance commissioners to effectively regulate the industry and protect consumers. The U.S. standard-setting organization is governed by the chief insurance regulators from the 50 states, the District of Columbia and five U.S. territories. Through the NAIC, state insurance regulators establish standards and best practices, conduct peer reviews, and coordinate regulatory oversight. NAIC staff supports these efforts and represents the collective views of state regulators domestically and internationally.

SOURCE NATIONAL ASSOCIATION OF INSURANCE COMMISSIONERS

Share this article

NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ServiceTitan, Inc. ("ServiceTitan" or the "Company") (NASDAQ: TTAN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The investigation concerns whether ServiceTitan and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here for information about joining the class action]

On September 8, 2026, ServiceTitan reported second quarter 2027 earnings. Among other items, the Company reported that "[b]ecause Max" – ServiceTitan's AI-powered enterprise software package – "requires substantial change management, we typically do not bill subscription fees for the first quarter of an upsell Max contract, and we have also elected not to charge existing customers an onboarding fee when transitioning to Max. As a result of these factors, we expect both our platform revenue and professional services revenue to grow at a slower pace for the remainder of fiscal 2027." The Company further reported that "[w]e expect the mix shift to Max to lower professional services revenue by roughly an additional $2 million over the remainder of this fiscal year, which, of course, also flows through to professional services gross margin."

On this news, ServiceTitan's stock price fell $24.46 per share, or 29.98%, to close at $57.12 per share on September 9, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Danielle Peyton

Pomerantz LLP

[email protected]

646-581-9980 ext. 7980

SOURCE Pomerantz LLP

Share this article

PUNE, India, Sept. 24, 2026 /PRNewswire/ -- The Global Bioinformatics Market was valued at USD 20.34 Billion in 2025 and is projected to expand at a 13.7% CAGR from 2026 to 2034, reaching USD 64.60 Billion by 2034, according to a new analysis by Maximize Market Research.

Global Bioinformatics Market

The Global Bioinformatics Market Report 2025 provides a comprehensive analysis of market trends, genomic data generation, next-generation sequencing (NGS), bioinformatics platforms, bioinformatics services, knowledge management tools, computational biology, biological databases, technology adoption, deployment models, application areas, end-user sectors, research activities, competitive developments, and market forecasts through 2034. The market covers genomics, proteomics, transcriptomics, metabolomics, molecular phylogenetics, chemoinformatics, and other bioinformatics applications across sequencing technology, microarray technology, mass spectrometry, high-throughput screening, data mining and machine learning, and structural bioinformatics tools.

The increasing volume of genomic and biological data, growing adoption of next-generation sequencing, expansion of precision medicine, rising pharmaceutical and biotechnology R&D, increasing demand for genomic data analysis, and broader application of computational biology are supporting the growth of the global bioinformatics market. Growing adoption of bioinformatics platforms, cloud-based bioinformatics, biological databases, data mining, machine learning, and AI-enabled analytical solutions is transforming genomics, drug discovery, molecular diagnostics, personalized medicine, and life-science research. Increasing investments in genomic research, sequencing infrastructure, biotechnology, pharmaceutical R&D, and computational technologies are further expanding opportunities for bioinformatics solution providers.

Advancements in artificial intelligence, machine learning, cloud computing, high-performance computing, genomic sequencing, biological data integration, data analytics, molecular modeling, and computational drug discovery are reshaping the bioinformatics landscape. Increasing research across genomics, proteomics, transcriptomics, metabolomics, chemoinformatics, and molecular phylogenetics is creating new opportunities for pharmaceutical and biotechnology companies, academic and research institutes, healthcare providers, and agricultural biotechnology organizations. Platform development, software innovation, strategic collaborations, genomic research initiatives, technology investments, data-management capabilities, and expansion of cloud-based bioinformatics solutions are expected to accelerate innovation and strengthen the global bioinformatics market through 2034.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @https://www.maximizemarketresearch.com/request-sample/207971/

Global Bioinformatics Market gains momentum as rising genomic data generation, increasing adoption of next-generation sequencing, growing demand for precision medicine, rapid integration of AI and machine learning, expansion of cloud-based bioinformatics, and advances in computational biology and genomic data analytics accelerate innovation: Maximize Market Research unveils key market insights.

Global Bioinformatics Market Size & Forecast

Global Bioinformatics Market Trends & Insights

- North America leads the Global Bioinformatics Market, supported by advanced pharmaceutical and biotechnology R&D, strong genomics infrastructure, high adoption of next-generation sequencing, precision medicine, and advanced bioinformatics platforms.

- Asia Pacific is the fastest-growing region, driven by expanding biotechnology and pharmaceutical industries, increasing genomic sequencing, healthcare digitization, investments in precision medicine, and rising adoption of cloud-based bioinformatics and computational tools.

- Genomics and next-generation sequencing are driving market demand, as the growing volume of genomic data increases the need for advanced sequencing analysis, biological databases, data mining, computational biology, and genomic data interpretation.

- AI, machine learning, and cloud computing are transforming bioinformatics, enabling faster biological data processing, predictive analytics, molecular analysis, automated workflows, drug discovery, and scalable genomic research across pharmaceutical, biotechnology, and academic institutions.

- Precision medicine and personalized healthcare are accelerating bioinformatics adoption, with increasing demand for pharmacogenomics, biomarker analysis, genomic diagnostics, molecular profiling, and computational approaches that support targeted therapies and data-driven drug development.

Bioinformatics Market Dynamics

Growing Genomic Data Generation and NGS Drives Market Growth

The increasing adoption of next-generation sequencing (NGS) is generating large volumes of genomic data, driving demand for bioinformatics platforms, sequencing data analysis, biological databases, and computational biology. Growing applications in genomics, precision medicine, molecular diagnostics, drug discovery, and pharmacogenomics are further supporting market growth. The declining cost of sequencing and expansion of sequencing capabilities are encouraging more research institutions, pharmaceutical companies, and biotechnology organizations to adopt advanced bioinformatics solutions. Increasing genomic research and the need for faster interpretation of complex biological datasets are also strengthening demand for computational tools.

High Infrastructure Costs and Data Security Concerns Restrain Market Growth

High costs associated with high-performance computing, specialized software, data storage, cloud infrastructure, and skilled professionals can limit bioinformatics adoption, particularly among smaller research organizations. Concerns surrounding genomic data privacy, cybersecurity, regulatory compliance, and interoperability also remain important market restraints. Managing large biological datasets requires secure and scalable infrastructure, increasing operational and technology requirements. Differences between databases and bioinformatics platforms can further create challenges in seamless data sharing and integration.

AI and Cloud-Based Bioinformatics Create Opportunities

Integration of AI, machine learning, cloud computing, data mining, predictive analytics, and automated workflows is creating new opportunities in genomic data analysis, drug discovery, biomarker identification, and molecular research. Cloud-based platforms provide scalable solutions for processing large biological datasets while reducing the need for extensive on-premise computing infrastructure. AI-driven tools can support genome interpretation, protein analysis, molecular modeling, sequence analysis, and computational drug discovery. Growing adoption of these technologies across pharmaceutical, biotechnology, healthcare, and academic research is expected to expand the application scope of bioinformatics.

Shortage of Skilled Professionals Creates Challenges

The growing complexity of genomic datasets, biological databases, sequencing technologies, computational algorithms, and analytical workflows is increasing demand for specialized bioinformatics professionals. Shortages of skilled talent with expertise across biology, computer science, statistics, data science, and molecular biology can restrict the efficient implementation of advanced solutions. Data standardization, interoperability, and integration challenges can also complicate the management of biological information across multiple platforms. These limitations may affect organizations seeking to establish large-scale bioinformatics infrastructure, genomic data analysis systems, and computational research capabilities.

Get Insightful Data on Regions, Market Segments, Customer Landscape, and Top Companies (Charts, Tables, Figures and More) https://www.maximizemarketresearch.com/request-sample/207971/

Global Bioinformatics Market Segmentation

The Global Bioinformatics Market is segmented by Product and Services, Technology, Deployment Model, Database Type, Application, End User Sector, and Region. Increasing genomic data generation, growing adoption of next-generation sequencing, rising demand for computational biology, AI and machine learning integration, expansion of cloud-based platforms, and increasing applications in precision medicine and drug discovery are supporting market development across these segments.

North America Leads the Bioinformatics Market While Asia Pacific Emerges as a High-Growth Region

North America held the largest share of the Global Bioinformatics Market in 2025, supported by strong pharmaceutical and biotechnology R&D, advanced genomics infrastructure, high adoption of next-generation sequencing (NGS), precision medicine, and computational biology. The United States represents a major market due to its established biotechnology ecosystem, genomic research capabilities, academic institutions, and adoption of bioinformatics platforms, biological databases, AI-driven analytics, and cloud-based bioinformatics solutions. Canada and Mexico are also contributing through expanding biotechnology activities, genomic research, and healthcare digitization.

Europe represents an important market, supported by established pharmaceutical and biotechnology industries, strong research institutions, advanced healthcare infrastructure, and increasing investment in genomics, proteomics, molecular diagnostics, and personalized medicine. Germany, the United Kingdom, France, Italy, Spain, Sweden, Austria, and other European countries are witnessing increasing adoption of bioinformatics software, sequencing data analysis, biological databases, computational biology, and AI-based research tools. Growth in genomic research and precision medicine is further supporting regional development.

Federal award will make CenterPoint one of the first U.S. utilities to deploy industry-leading substation technology to enhance resiliency, reliability and respond to increases in energy demand.

HOUSTON, Sept. 24, 2026 /PRNewswire/ -- Today, the U.S. Department of Energy (DOE) and Assistant Secretary for the DOE's Office of Electricity Katie Jereza announced the selection of CenterPoint Energy for a $50 million award to support advanced substation technology upgrades. Following finalization of negotiations with DOE, this award will help fund and support CenterPoint Energy's ongoing efforts to strengthen electric reliability and resiliency and increase energy capacity for one of the fastest growing regions in Texas and the nation.

"Our mission is to build the most resilient coastal grid in the nation for the 2.9 million customers we proudly serve in the Greater Houston area, and we're grateful to the DOE for this vital investment in both Houston's and Texas's energy infrastructure. This selection is historic for our region, and it will directly fund industry-leading technology improvements that are expected to strengthen resiliency, reliability and meet the growing energy needs of our region," said Jason Ryan, CenterPoint Energy's Executive Vice President, Regulatory Services & Government Affairs.

Historic Energy Infrastructure Investment: Critical Substation Improvements

With the DOE project, CenterPoint Energy will become one of the first utilities in the nation to install Siemens Energy's industry-leading, transmission grid stabilizing technology, which can respond rapidly to changes in electricity demand and help maintain reliable service for local customers. The key expected benefits from this advanced technology project include:

- Strengthening resiliency and reliability during periods of high demand;

- Increasing capacity to meet current and future demand and economic growth;

- Expected to create more than 500 local jobs to support project construction and installation.

The funding will prove critical to the region's energy future and was selected through DOE's Speed to Power through Accelerated Reconductoring and other Key Advanced Transmission Technology Upgrades (SPARK) program. The SPARK Program supports projects that modernize existing electrical infrastructure and help ensure our nation's utilities reliably meet growing energy demand and lower electricity costs for approximately 100 million Americans.

"Through the SPARK program, we are investing in vital projects across the country that expand energy grid capacity, strengthen reliability and resiliency, and support the economic development of communities. The Department of Energy is proud to support forward-looking infrastructure improvements that will help power growth and dependable energy for the Houston area," said Katie Jereza, Assistant Secretary, U.S. Department of Energy's Office of Electricity.

"Generations of CenterPoint customers and families in the region will benefit from the advanced technology this grant is funding," said Commissioner Kathleen Jackson, Public Utility Commissioner of Texas. "And anytime companies make improvements like this to their systems, the long-term impact is making the entire grid stronger for Texans."

To learn more about CenterPoint Energy's resiliency and reliability improvements across Greater Houston, please visit CenterPointEnergy.com/Progress.

About CenterPoint Energy, Inc.

As the only investor owned electric and gas utility based in Texas, CenterPoint Energy, Inc. (NYSE: CNP) is an energy delivery company with electric transmission and distribution, power generation and natural gas distribution operations that serve more than 7 million metered customers in Indiana, Minnesota and Texas. As of June 30, 2026, the company owned approximately $48.3 billion in assets. With approximately 8,800 employees, CenterPoint Energy and its predecessor companies have been in business for more than 150 years. For more information, visit CenterPointEnergy.com.

Forward-Looking Statement

This news release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon assumptions of management which are believed to be reasonable at the time made and are subject to significant risks and uncertainties. Actual events and results may differ materially from those expressed or implied by these forward-looking statements. Any statements in this news release regarding future events, such as the implementation of advanced substation technology upgrades and the benefits therefrom (including jobs creation), the reliability and resiliency of the electric grid, and any other statements that are not historical facts are forward-looking statements. Each forward-looking statement contained in this news release speaks only as of the date of this release. Important factors that could cause actual results to differ materially from those indicated by the provided forward-looking information include risks and uncertainties relating to: (1) business strategies and strategic initiatives involving CenterPoint Energy or its industry; (2) CenterPoint Energy's ability to fund and invest planned capital, and the timely recovery of its investments; (3) financial market and general economic conditions; (4) the timing and impact of future regulatory, legislative and political actions or developments; and (5) other factors, risks and uncertainties discussed in CenterPoint Energy's Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and CenterPoint's Quarterly Report on Form 10-Q for the quarters ended March 31, 2026 and June 30, 2026 and other reports CenterPoint Energy or its subsidiaries may file from time to time with the Securities and Exchange Commission.

For more information, contact:

Communications

[email protected]

SOURCE CenterPoint Energy

Share this article

NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Today, the N7 Foundation convened a high-level roundtable, chaired by N7 Chairman Jeffrey M. Talpins, with U.S. Under Secretary of State Allison Hooker and her counterparts from the Kingdom of Bahrain, the State of Israel, the Republic of Kazakhstan, the Kingdom of Morocco, and the United Arab Emirates, to discuss the future of the Abraham Accords and opportunities to deepen regional cooperation. The N7 roundtable is the first meeting of the Accords countries since January 2023, and the first official engagement to include Kazakhstan.

Officials reaffirmed the principles of the Abraham Accords and recognized that the Middle East's vast potential can be unlocked through coexistence, mutual understanding, and cooperation between Israel, its Arab and Muslim neighbors, the United States, and likeminded partners. Officials welcomed Kazakhstan's forthcoming ascension to the Accords and stressed the importance of tangible outcomes on shared priorities, noting that such cooperation can promote regional stability and security and provide a platform for peace and prosperity.

"The Abraham Accords have demonstrated what is possible when countries come together around shared interests with a common vision for a more integrated and prosperous region," said Mr. Jeffrey M. Talpins, Chairman & Founder of the N7 Foundation. "The next phase is about deepening the relationships that already exist and identifying practical opportunities for countries to work together. The N7 Foundation is committed to advancing this future and transforming the Abraham Accords into a forum for strategic, regional cooperation."

"The Abraham Accords have created a foundation for a more connected region, and their full potential will be realized through the practical cooperation they make possible," said Oren Eisner, President of the N7 Foundation. "Today's discussion focused on the work ahead: strengthening existing relationships, welcoming new partners, and advancing initiatives that deliver tangible benefits to people and economies across the region."

Building on its historic role hosting the first ever multilateral convening of the Accords countries in 2021, the N7 Foundation will continue to work with Accords countries and aligned partners to further develop the next chapter of the Accords, with an emphasis on deepening and expanding cooperation and transforming shared interests into concrete benefits for all members. The N7 Foundation will explore durable mechanisms for strategic, multilateral cooperation that can elevate partnership through the Accords. This, we believe, can help cultivate a future for the region that is more stable, secure, integrated, prosperous, and interconnected with the world.

About the N7 Foundation:

The N7 Foundation is a nonpartisan policy development and convening platform dedicated to strengthening and broadening relations among the United States, Israel, and Arab and Muslim countries. Our efforts are guided by our principal belief that enhanced cooperation among these countries will generate significant benefits to the region and advance strategic U.S. interests. We believe in the power and potential of a more peaceful, secure, integrated Middle East, interconnected with the world.

Contact: [email protected]

SOURCE N7 Foundation

Share this article

New Cox Automotive research finds 63% of vehicle shoppers plan to use AI, while only 29% of dealers say they are adjusting for AI-powered search

SAN ANTONIO, Sept. 24, 2026 /PRNewswire/ -- CarLocal.io is expanding its automotive AI answer engine and dealership visibility infrastructure as artificial intelligence becomes a more important starting point in the vehicle-shopping journey.

The shift is already showing up in industry research. According to Cox Automotive's Q2 2026 AI in Auto Retail Tracker, 63% of in-market vehicle shoppers say they definitely or probably will use AI during their next vehicle purchase. AI tools are now used as a vehicle research channel by 36% of shoppers, nearly level with automotive-specific websites at 38%.

Dealer adoption, however, has not moved at the same pace. Cox reports that only 29% of dealers say they are actively adjusting or in the process of adjusting for AI-powered search.

That creates a new challenge for automotive retailers: When a shopper asks an AI platform what vehicle to buy, where to buy it, how much it should cost or where to have it serviced, will that dealership be part of the answer?

"The biggest change isn't simply that consumers are using AI," said Chris J. Martinez, founder of CarLocal.io. "It's that the starting point of the shopping journey can now be a question instead of a traditional search. Dealers have spent years competing to rank on Google. The next challenge is making sure their dealership, inventory and local expertise can be understood and surfaced when consumers ask AI for an answer."

CarLocal.io is building around that shift.

The platform combines automotive AI search, answer engine optimization (AEO), generative engine optimization (GEO), structured dealership information, local automotive intent coverage and technical website infrastructure designed to make dealership information easier for search engines and AI systems to discover, interpret and connect.

The consumer-facing CarLocal experience is being developed to answer natural-language automotive questions, while the underlying infrastructure helps organize and connect dealership information across traditional search, answer engines and emerging AI interfaces.

The goal is straightforward: help local dealerships become part of the answer as automotive discovery moves from searching to asking.

How Vehicle Discovery Is Changing

The change is visible in the types of questions consumers can now ask conversational systems. Instead of searching only for a dealership or vehicle model, a shopper can ask which three-row SUV fits a specific budget, whether leasing or financing makes more sense for a particular situation, what to consider before buying a used electric vehicle, or where to service a vehicle locally.

Cox Automotive reported that among shoppers using AI, 26% use it to generate questions to ask dealers and 24% say it helps them feel more prepared when working with a dealership. Avoiding dealership staff was the least-cited dealer-relationship benefit at 17%, suggesting AI is often being used to prepare for the dealership interaction rather than eliminate it.

"The important change is not simply that consumers are using AI," said Chris J. Martinez, founder of CarLocal.io. "It is that the starting point can now be a question instead of a website. That changes what information needs to be available, how it needs to be structured and how a local dealership can become part of the answer."

What CarLocal Is Building

CarLocal is developing an automotive AI answer engine and dealership visibility platform around the shift from keyword search toward conversational discovery. The consumer-facing experience is designed to address natural-language automotive questions, while the underlying infrastructure organizes dealership information so it can be more readily interpreted across traditional search, answer engines and emerging AI interfaces.

What CarLocal Is Finding on Dealership Websites

CarLocal's internal analysis of automotive retail websites has identified recurring technical and content issues that can complicate machine discovery. These include orphaned content with weak or missing internal pathways, conflicting canonical signals, sitemap gaps, inconsistent dealership information and promotional language that cannot be tied to a current verified offer.

In a recent quality initiative across CarLocal's dealership network, the platform corrected more than 11,000 promotional claims, removed more than 23,000 unsupported promotional references from page content and resolved 573 canonical conflicts. CarLocal also applied more than 68,000 internal links to strengthen connections between automotive content and reduce orphaned pages.

These figures are internal operational findings from CarLocal's platform work, not an independent industry sample. They are included to show the types and scale of issues CarLocal has encountered within the dealership websites it currently supports and should not be generalized to all U.S. dealerships.

How CarLocal Is Responding

The platform combines traditional search-engine fundamentals with answer engine optimization (AEO), generative engine optimization (GEO), structured dealership information and local automotive intent coverage. CarLocal is also developing MCP-ready infrastructure around the Model Context Protocol, an open standard for connecting AI applications with external data sources and tools.

Within CarLocal's architecture, MCP is one component intended to prepare dealership information for a future in which AI assistants and agents may retrieve information, use external tools and help consumers move from research toward action through conversational interfaces. The consumer sees an answer; underneath it is an information layer intended to organize automotive knowledge and connect consumer intent with relevant local resources.

CarLocal separately evaluates whether content is technically accessible, whether it meets internal quality requirements and whether visibility can actually be observed. Publishing or analyzing a page is not counted as proof that an external search engine or AI system has surfaced it.

CarLocal.io Platform Metrics

As of September 2026, CarLocal supports 21 active dealership deployments and has analyzed more than 49,000 live automotive web pages. These figures describe platform deployment and technical analysis activity; they are not presented as independent evidence of consumer adoption, search-ranking gains or AI citation performance.

The quality initiative figures cited above are also internal operational counts. CarLocal reports them separately from third-party market research so readers can distinguish external consumer and dealer trends from observations generated through CarLocal's own platform.

Methodology and Sources

The consumer and dealer market statistics in this release come from Cox Automotive's AI in Auto Retail Tracker. Cox reports that its Q2 2026 wave surveyed 483 franchise and independent dealership decision-makers and 1,502 consumers planning to purchase a vehicle within the next 12 months. The Q2 surveys were fielded in May 2026, and dealership data were weighted by dealership size.

CarLocal platform figures are internal operational counts as of September 2026. They reflect active dealership deployments and pages processed or analyzed by CarLocal systems. They are provided for scale and product context and should not be interpreted as third-party market research.

Sources

Cox Automotive, AI in Auto Retail Tracker (Q1–Q2 2026): https://www.coxautoinc.com/retail/ai-in-auto-retail-tracker/

Cox Automotive, "New Cox Automotive AI in Auto Retail Tracker Finds Growing Gap Between Dealers and AI-Powered Car Shoppers," Aug. 11, 2026: https://www.coxautoinc.com/press-releases/new-cox-automotive-ai-in-auto-retail-tracker/

Cox Automotive, "How AI Is Influencing Vehicle Discovery and What Dealers Can Do About It," Aug. 26, 2026: https://www.coxautoinc.com/insights/how-ai-is-influencing-vehicle-discovery-and-what-dealers-can-do-about-it/

About CarLocal.io

CarLocal.io is an automotive AI answer engine and search visibility platform focused on helping consumers navigate vehicle research and ownership questions while helping local dealerships make accurate information more discoverable across traditional search, answer engines and generative AI. Its technology includes dealership website analysis, AEO, GEO, structured information, local intent coverage, content quality controls and MCP-ready infrastructure.

SOURCE CarLocal

Share this article